Auto, Tyres Surge on Q4 Earnings; FMCG Dips as Demand Falters

ECONOMY
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Auto, Tyres Surge on Q4 Earnings; FMCG Dips as Demand Falters
Overview

Indian companies are releasing Q4 earnings, showing a clear split. Auto and tyre makers, including MRF, are expected to perform strongly. However, consumer goods companies like Dabur India face slower sales and higher costs. The market favors sectors that are showing strong demand and efficient operations.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

A wave of Q4 earnings reports is revealing how Indian companies finished the fiscal year. The results show sharply different trends across sectors. Companies like Bharat Forge and MRF are set for strong results, boosted by solid demand and efficient operations. Others, however, are navigating a tougher climate due to weaker consumer spending and rising costs.

Auto and Tyre Sectors Show Strength

Automotive parts makers and tyre companies are seeing strong performance. Bharat Forge is expected to report around ₹369.8 crore in profit on nearly ₹4,560 crore in revenue, showing efficient operations. Tyre maker MRF has already posted its Q4 FY25 results: net profit jumped 31% year-over-year to ₹498 crore, with revenue up 12% to ₹6,944 crore. MRF also announced a ₹229 per share final dividend. Escorts Kubota is also forecast to deliver solid earnings, with revenue around ₹2,976 crore and profit near ₹341 crore. This indicates a healthy demand in the auto and industrial sectors.

FMCG Faces Consumer Headwinds

The Fast-Moving Consumer Goods (FMCG) sector faces a different picture. Dabur India is expected to post ₹353.07 crore profit on ₹3,044 crore revenue. However, its actual Q4 FY25 results revealed a profit decline to ₹320.13 crore and very little revenue growth, causing its stock to fall. Dabur cited weaker demand in cities and high food inflation as key challenges, even though its international business performed well.

Pharma's Mixed Performance

Pharmaceutical firms show mixed results. Lupin is projected to report strong earnings, with profit over ₹1,200 crore on ₹6,909 crore revenue and a 27.2% margin. Biocon, meanwhile, faces investor attention with a high P/E ratio, despite expected profits of ₹223.2 crore on ₹4,482 crore revenue.

Company Valuations Vary Widely

Valuations differ greatly among these companies, reflecting their growth prospects and market sentiment. Bharat Forge has a P/E ratio near 79.2, suggesting high expectations for future growth. Tyre market leader MRF trades at a P/E of about 24.17, seen as more balanced after its latest results. Escorts Kubota and Lupin have P/E ratios around 27.22 and 22.95, respectively. Pidilite Industries, a varied consumer goods company, holds a P/E of about 60, driven by its strong brand. Dabur India's P/E is around 56.52, which seems high given its recent profit dip and slow growth outlook. Biocon's P/E is very high, between 73.78 and over 92.57, possibly indicating strong biotech growth expectations or a large premium.

Risks for Certain Companies

While auto and tyre sectors show promise, some companies face specific risks. Dabur India's dependence on city dwellers and sensitivity to inflation mean ongoing concerns, especially after its recent earnings miss and stock drop. Its P/E ratio may remain high if demand doesn't improve. Biocon's very high P/E ratio is risky; any failure to meet high growth targets could sharply lower its valuation. Bharat Forge's P/E of about 79.2 means it's priced for significant future growth, making it vulnerable if that growth slows. Wider economic factors, like interest rate changes or global uncertainties, could also affect profit margins for many companies.

Looking Ahead

Dabur India plans a seven-point strategy to reach double-digit revenue growth by FY28, focusing on brand investment and offering more premium products. MRF's strong Q4 results and dividend payout signal confidence in its market standing. Analysts hold a neutral view on MRF, with an average 12-month price target of roughly ₹149,866, suggesting cautious optimism. The automotive sector's future looks bright due to strong demand, while FMCG firms hope for a slow recovery in consumer spending. The pharma sector's success will depend on its product pipeline and the regulatory landscape.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.